Code Biotherapeutics, Inc. — Form D

Code Biotherapeutics, Inc. of HATFIELD, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-09. The offering totals $75.0M, of which $37.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Russ FeinDirectorLouisville, CO
Dmitry KuzminDirectorSt Peter Port, Y7
Robert LinDirectorHatfield, PA
Edward MathersDirectorSouth San Francisco, CA
Brian McVeighDirectorHatfield, PA
Kathy RouanDirectorHatfield, PA
Victor StoneDirectorHatfield, PA
Joseph TruittDirectorHatfield, PA
Erin C BrubakerExecutive OfficerHatfield, PA
Russ FeinExecutive OfficerLouisville, CO
Robert C GettsExecutive OfficerHatfield, PA
Lauren C KaskielExecutive OfficerHatfield, PA
Brian McVeighExecutive OfficerHatfield, PA
Dmitry C KuzminDirectorHatfield, PA
Victor C StoneDirectorHatfield, PA
Edward C MathersDirectorHatfield, PA
Robert C LinDirectorHatfield, PA

Other filings by this issuer (2)

FiledFormOfferingSold
2021-04-21D/A$10.0M$10.0M
2021-03-22D$10.0M$5.0M

More